Literature DB >> 14682062

Immune-deficient mouse models for analysis of human stem cells.

Todd E Meyerrose1, Phillip Herrbrich, David A Hess, Jan A Nolta.   

Abstract

The field of murine models of xenotransplantation has grown immensely over the past two decades. The explosive growth in this field is in part due to the fact that good in vitro methods do not exist yet to allow examination of human stem cell homing into the bone marrow compartment versus other tissues, long-term survival of human stem cells, or differentiation into tissues outside of the hematopoietic system. Since these important aspects of human stem cell biology can be examined in vivo using immune-deficient mice, the number of different strains and models is constantly increasing. The current review discusses the merits and drawbacks of each immune-deficient mouse xenograft system as it stands to date and reviews how each immune-deficient mouse model has been used to further our knowledge of human hematopoietic stem cell biology.

Entities:  

Mesh:

Year:  2003        PMID: 14682062     DOI: 10.2144/03356ss06

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  18 in total

1.  High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells.

Authors:  Suzan Imren; Mary E Fabry; Karen A Westerman; Robert Pawliuk; Patrick Tang; Patricia M Rosten; Ronald L Nagel; Philippe Leboulch; Connie J Eaves; R Keith Humphries
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 2.  Hematopoietic stem cells.

Authors:  Robert G Hawley; Ali Ramezani; Teresa S Hawley
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.

Authors:  David A Hess; Louisa Wirthlin; Timothy P Craft; Phillip E Herrbrich; Sarah A Hohm; Ryan Lahey; William C Eades; Michael H Creer; Jan A Nolta
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

Review 4.  Pathogenesis and treatment of human T-cell leukemia virus infection.

Authors:  Lee Ratner
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction.

Authors:  Claus S Sondergaard; David A Hess; Dustin J Maxwell; Carla Weinheimer; Ivana Rosová; Michael H Creer; David Piwnica-Worms; Attila Kovacs; Lene Pedersen; Jan A Nolta
Journal:  J Transl Med       Date:  2010-03-09       Impact factor: 5.531

6.  SCID dogs: similar transplant potential but distinct intra-uterine growth defects and premature replicative senescence compared with SCID mice.

Authors:  Katheryn Meek; Ari Jutkowitz; Lisa Allen; Jillian Glover; Erin Convery; Alisha Massa; Tom Mullaney; Bryden Stanley; Diana Rosenstein; Susan M Bailey; Cheri Johnson; George Georges
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

7.  Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury.

Authors:  Janice M Liebler; Carolyn Lutzko; Agnes Banfalvi; Dinithi Senadheera; Neema Aghamohammadi; Edward D Crandall; Zea Borok
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-30       Impact factor: 5.464

8.  In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors.

Authors:  Gerhard Bauer; Mo A Dao; Scott S Case; Todd Meyerrose; Louisa Wirthlin; Ping Zhou; Xiuli Wang; Phillip Herrbrich; Jesusa Arevalo; Susie Csik; Dianne C Skelton; Jon Walker; Karen Pepper; Donald B Kohn; Jan A Nolta
Journal:  Mol Ther       Date:  2008-05-06       Impact factor: 11.454

9.  Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation.

Authors:  Bruno C Huber; Julia D Ransohoff; Katherine J Ransohoff; Johannes Riegler; Antje Ebert; Kazuki Kodo; Yongquan Gong; Veronica Sanchez-Freire; Devaveena Dey; Nigel G Kooreman; Sebastian Diecke; Wendy Y Zhang; Justin Odegaard; Shijun Hu; Joseph D Gold; Robert C Robbins; Joseph C Wu
Journal:  Stem Cells       Date:  2013-11       Impact factor: 6.277

10.  Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells.

Authors:  George S Wilson; Zenan Hu; Wei Duan; Aiping Tian; Xin M Wang; Duncan McLeod; Vincent Lam; Jacob George; Liang Qiao
Journal:  Stem Cells Dev       Date:  2013-06-08       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.